Sleep for Stroke Management and Recovery Trial
Purpose
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Conditions
- Ischemic Stroke
- Sleep Apnea
- Sleep Apnea, Obstructive
- TIA
- Stroke
- CPAP
- Telemedicine
- Home Sleep Apnea Test
- Randomized Clinical Trial
- Multicenter Trial
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- TIA with ABCD2 ≥4 or ischemic stroke, within the prior 14 days.
Exclusion Criteria
- pre-event inability to perform all of own basic ADLs 2. unable to obtain informed consent from subject or legally authorized representative 3. incarcerated 4. known pregnancy 5. current mechanical ventilation (can enroll later if this resolves) or tracheostomy 6. current use of positive airway pressure, or use within one month prior to stroke 7. anatomical or dermatologic anomaly that makes use of CPAP interface unfeasible 8. severe bullous lung disease 9. history of prior spontaneous pneumothorax or current pneumothorax 10. hypotension requiring current treatment with pressors (can enroll later if this resolves) 11. other specific medical circumstances that conceivably, in the opinion of the site PI, could render the patient at risk of harm from use of CPAP 12. massive epistaxis or previous history of massive epistaxis 13. cranial surgery or head trauma within the past 6 months, with known or possible CSF leak or pneumocephalus 14. recent hemicraniectomy or suboccipital craniectomy (i.e. those whose bone has not yet been replaced), or any other recent bone removal procedure for relief of intracranial pressure 15. current receipt of oxygen supplementation >4 liters per minute 16. current contact, droplet, respiratory/airborne precautions
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Intervention Model Description
- Intervention group receives automatically adjusting continuous positive airway pressure (CPAP) plus usual care.The control group receives usual care.
- Primary Purpose
- Prevention
- Masking
- Single (Outcomes Assessor)
- Masking Description
- Eligible participants will be allocated in a 1:1 fashion to CPAP or no CPAP using a randomization method to protect subject treatment allocation and prevent potential selection biases.
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Intervention Arm: CPAP with Usual Care. |
6 months of CPAP plus usual medical therapy. |
|
No Intervention Control Arm: Usual Care. |
6 months of usual medical therapy alone. |
|
Recruiting Locations
New York, New York 10032
Cleveland, Ohio 11100
Cincinnati, Ohio 45219
Winston-Salem, North Carolina 27157
Greensboro, North Carolina 27401
Concord, North Carolina 28025
Charlotte, North Carolina 28203
Staten Island, New York 10305
Rochester, New York 14642
New York, New York 10016
Manhasset, New York 11030
Albuquerque, New Mexico 87106
Springfield, Missouri 65807
Kansas City, Missouri 64111
Saint Cloud, Minnesota 56303
Dallas, Texas 75246
La Crosse, Wisconsin 54601
Morgantown, West Virginia 26506
Seattle, Washington 98101
Burlington, Vermont 05401
Salt Lake City, Utah 84132
Houston, Texas 77030
Sioux Falls, South Dakota 57108
Greenville, South Carolina 29605
Columbia, South Carolina 29203
Philadelphia, Pennsylvania 19122
Philadelphia, Pennsylvania 19104
Hershey, Pennsylvania 17033
Bethlehem, Pennsylvania 18015
Portland, Oregon 97225
Jackson, Mississippi 39216
Rochester, Minnesota 55905
Chandler, Arizona 85224
Modesto, California 95355
Grand Junction, Colorado 81501
Walnut Creek, California 94598
Santa Ana, California 92705
San Francisco, California 94143
San Diego, California 92103
Los Angeles, California 94612
Washington, District of Columbia 20037
Los Angeles, California 90095
Los Angeles, California 90048
La Jolla, California 92037
Downey, California 90242
Carmichael, California 95608
Tucson, Arizona 85719
Phoenix, Arizona 85013
Phoenix, Arizona 85006
New Haven, Connecticut 06510
Gainesville, Florida 32611
Iowa City, Iowa 52242
Boston, Massachusetts 02215
Boston, Massachusetts 02115
Boston, Massachusetts 02114
Baltimore, Maryland 21201
Shreveport, Louisiana 71103
New Orleans, Louisiana 70121
Peoria, Illinois 61603
Chicago, Illinois 60637
Chicago, Illinois 60612
Sarasota, Florida 34239
Jacksonville, Florida 32216
Madison, Wisconsin 53715
More Details
- NCT ID
- NCT03812653
- Status
- Recruiting
- Sponsor
- University of Michigan
Detailed Description
Sleep SMART has a prospective, randomized, open-label, blinded-endpoint (PROBE) design. It is a multi-site, parallel-group superiority trial that compares 6 months of OSA treatment to usual care. The study includes two trials: a prevention study with an embedded recovery trial. 3062 subjects will be randomized over 5 years at 110 sites within the NINDS-funded StrokeNet clinical trials network.